SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000069499-03-000045
Filing Date
2003-08-14
Accepted
2003-08-14 16:02:00
Documents
1
Period of Report
2003-08-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 22628
  Complete submission text file 0000069499-03-000045.txt   24604
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Issuer) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUITE 340 MELLON PAVILION PITTSBURGH PA 15224
Business Address SUITE 340 MELLON PAVILION PITTSBURGH PA 15224 4126815266
GAISFORD JOHN C DR (Reporting) CIK: 0001114100 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-09114 | Film No.: 03847695